Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug
Clinical trial NCT03235726 · COMPLETED
Trial details
- NCT number
- NCT03235726
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-13
- Primary completion
- 2018-06-19
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.